JP2019521155A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019521155A5 JP2019521155A5 JP2019501928A JP2019501928A JP2019521155A5 JP 2019521155 A5 JP2019521155 A5 JP 2019521155A5 JP 2019501928 A JP2019501928 A JP 2019501928A JP 2019501928 A JP2019501928 A JP 2019501928A JP 2019521155 A5 JP2019521155 A5 JP 2019521155A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- composition according
- breast
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 206010006187 Breast cancer Diseases 0.000 claims 3
- 208000026310 Breast neoplasm Diseases 0.000 claims 3
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 239000013078 crystal Substances 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021167806A JP7263473B2 (ja) | 2016-07-18 | 2021-10-13 | Ｔｔｋ阻害剤の固体形態 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662363424P | 2016-07-18 | 2016-07-18 | |
| US62/363,424 | 2016-07-18 | ||
| PCT/CA2017/050848 WO2018014116A1 (en) | 2016-07-18 | 2017-07-13 | Solid forms of ttk inhibitor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021167806A Division JP7263473B2 (ja) | 2016-07-18 | 2021-10-13 | Ｔｔｋ阻害剤の固体形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019521155A JP2019521155A (ja) | 2019-07-25 |
| JP2019521155A5 true JP2019521155A5 (https=) | 2020-08-20 |
| JP6961675B2 JP6961675B2 (ja) | 2021-11-05 |
Family
ID=60991755
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019501928A Active JP6961675B2 (ja) | 2016-07-18 | 2017-07-13 | Ｔｔｋ阻害剤の固体形態 |
| JP2021167806A Active JP7263473B2 (ja) | 2016-07-18 | 2021-10-13 | Ｔｔｋ阻害剤の固体形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021167806A Active JP7263473B2 (ja) | 2016-07-18 | 2021-10-13 | Ｔｔｋ阻害剤の固体形態 |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US10584130B2 (https=) |
| EP (1) | EP3484888B1 (https=) |
| JP (2) | JP6961675B2 (https=) |
| KR (2) | KR102700233B1 (https=) |
| CN (2) | CN115093416B (https=) |
| AU (2) | AU2017299850B2 (https=) |
| BR (1) | BR112019000813A2 (https=) |
| DK (1) | DK3484888T3 (https=) |
| ES (1) | ES2945108T3 (https=) |
| FI (1) | FI3484888T5 (https=) |
| HR (1) | HRP20230481T1 (https=) |
| HU (1) | HUE061872T2 (https=) |
| IL (1) | IL264173B2 (https=) |
| LT (1) | LT3484888T (https=) |
| MA (1) | MA45691A (https=) |
| MX (2) | MX385289B (https=) |
| PL (1) | PL3484888T3 (https=) |
| PT (1) | PT3484888T (https=) |
| RS (1) | RS64210B1 (https=) |
| RU (2) | RU2753905C2 (https=) |
| SG (2) | SG10202103332UA (https=) |
| SI (1) | SI3484888T1 (https=) |
| SM (1) | SMT202300156T1 (https=) |
| TW (2) | TWI745400B (https=) |
| WO (1) | WO2018014116A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017299850B2 (en) | 2016-07-18 | 2021-05-27 | University Health Network | Solid forms of TTK inhibitor |
| KR20240175121A (ko) | 2023-06-12 | 2024-12-19 | 한국재료연구원 | 희토류 산화물을 이용한 입계확산물질의 제조방법 및 이를 이용한 R-Fe-B계 영구자석의 제조방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2438092C (en) | 2001-02-21 | 2011-08-09 | Chiron Corporation | Ttk in diagnosis and as a therapeutic target in cancer |
| ATE482213T1 (de) * | 2004-11-04 | 2010-10-15 | Vertex Pharma | Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine |
| TW201107329A (en) * | 2009-07-30 | 2011-03-01 | Oncotherapy Science Inc | Fused imidazole derivative having ttk inhibitory action |
| TWI541243B (zh) * | 2010-09-10 | 2016-07-11 | 拜耳知識產權公司 | 經取代咪唑并嗒 |
| CN103415518A (zh) * | 2010-12-17 | 2013-11-27 | 拜耳知识产权有限责任公司 | 在过度增殖性病症的治疗中用作mps-1和tkk抑制剂的咪唑并吡嗪 |
| US9573954B2 (en) * | 2012-11-16 | 2017-02-21 | University Health Network | Pyrazolopyrimidine compounds |
| JP6095857B2 (ja) * | 2013-11-15 | 2017-03-15 | ユニバーシティ・ヘルス・ネットワーク | ピラゾロピリミジン化合物 |
| AU2017299850B2 (en) | 2016-07-18 | 2021-05-27 | University Health Network | Solid forms of TTK inhibitor |
-
2017
- 2017-07-13 AU AU2017299850A patent/AU2017299850B2/en active Active
- 2017-07-13 ES ES17830139T patent/ES2945108T3/es active Active
- 2017-07-13 JP JP2019501928A patent/JP6961675B2/ja active Active
- 2017-07-13 EP EP17830139.6A patent/EP3484888B1/en active Active
- 2017-07-13 HR HRP20230481TT patent/HRP20230481T1/hr unknown
- 2017-07-13 CN CN202210644487.1A patent/CN115093416B/zh active Active
- 2017-07-13 SI SI201731352T patent/SI3484888T1/sl unknown
- 2017-07-13 KR KR1020237017039A patent/KR102700233B1/ko active Active
- 2017-07-13 SG SG10202103332UA patent/SG10202103332UA/en unknown
- 2017-07-13 BR BR112019000813-6A patent/BR112019000813A2/pt active Search and Examination
- 2017-07-13 FI FIEP17830139.6T patent/FI3484888T5/fi active
- 2017-07-13 RU RU2019101109A patent/RU2753905C2/ru active
- 2017-07-13 CN CN201780043473.1A patent/CN109476667B/zh active Active
- 2017-07-13 SG SG11201900113UA patent/SG11201900113UA/en unknown
- 2017-07-13 IL IL264173A patent/IL264173B2/en unknown
- 2017-07-13 HU HUE17830139A patent/HUE061872T2/hu unknown
- 2017-07-13 US US16/318,426 patent/US10584130B2/en active Active
- 2017-07-13 KR KR1020197001829A patent/KR102537088B1/ko active Active
- 2017-07-13 MA MA045691A patent/MA45691A/fr unknown
- 2017-07-13 PT PT178301396T patent/PT3484888T/pt unknown
- 2017-07-13 RU RU2021124795A patent/RU2021124795A/ru unknown
- 2017-07-13 RS RS20230383A patent/RS64210B1/sr unknown
- 2017-07-13 MX MX2019000744A patent/MX385289B/es unknown
- 2017-07-13 WO PCT/CA2017/050848 patent/WO2018014116A1/en not_active Ceased
- 2017-07-13 LT LTEPPCT/CA2017/050848T patent/LT3484888T/lt unknown
- 2017-07-13 PL PL17830139.6T patent/PL3484888T3/pl unknown
- 2017-07-13 SM SM20230156T patent/SMT202300156T1/it unknown
- 2017-07-13 DK DK17830139.6T patent/DK3484888T3/da active
- 2017-07-18 TW TW106123975A patent/TWI745400B/zh active
- 2017-07-18 TW TW110137560A patent/TWI824313B/zh active
-
2019
- 2019-01-17 MX MX2021008658A patent/MX2021008658A/es unknown
-
2020
- 2020-03-02 US US16/806,392 patent/US11104681B2/en active Active
-
2021
- 2021-08-24 AU AU2021221447A patent/AU2021221447B2/en active Active
- 2021-08-27 US US17/459,725 patent/US11878980B2/en active Active
- 2021-10-13 JP JP2021167806A patent/JP7263473B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125855T1 (el) | Αναστολεις της ειδικης για τη λυσινη απομεθυλασης-1 | |
| CY1123475T1 (el) | Αναστολεις της ειδικης για λυσινη απομεθυλασης-1 | |
| CY1120903T1 (el) | Ενωσεις αμινοπυριδυλοξυπυραζολιου | |
| JP2019526543A5 (https=) | ||
| JP2015503422A5 (https=) | ||
| EA201891526A2 (ru) | Ингибиторы лизин-специфической деметилазы-1 | |
| MX2016010266A (es) | Formas solidas cristalinas de n-{4-[(6,7-dimetoxiquinolin-4-il)oxi ]fenil}-n'-(4-fluorofenil)ciclopropan-1,1-dicarboxamida, procesos para elaboracion y metodos de uso. | |
| PH12015501744A1 (en) | Therapeutic and diagnostic target for cancer comprising dll3 binding reagents | |
| GEP20237496B (en) | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer | |
| IL270717A (en) | Biomarkers for diagnosis of lung cancer | |
| HUE053191T2 (hu) | 2-Heteroaril-3-oxo-2,3-dihidropiridazin-4-karboxamidok rák kezelésére | |
| EA201790082A1 (ru) | Ингибиторы лизин-специфической демитилазы-1 | |
| EA201692100A1 (ru) | Новые антитела против rnf43 и способы их применения | |
| MX2016011072A (es) | Derivado de pirazol amida. | |
| MX375219B (es) | Inhibidores de histona demetilasa. | |
| LT3458610T (lt) | Krūties vėžio terapinis gydymas, remiantis c-maf būkle | |
| LT3416957T (lt) | 6-heterociklil-4-morfolin-4-ilpiridin-2-ono junginiai, tinkami vėžio ir diabeto gydymui | |
| HUE050863T2 (hu) | Rák és cukorbetegség kezelésére alkalmazható 6-aril-4-(morfolin-4-il)-1H-piridin-2-on vegyületek | |
| SI3720433T1 (sl) | Bis-holin tetratiomolibdat za zdravljenje Wilsonove bolezni | |
| EP3583113C0 (en) | Immunotherapeutic combination for the treatment of TGF-alpha-expressing lung cancer or TGF-alpha-expressing melanoma | |
| DK3241551T3 (da) | Farmaceutisk sammensætning til behandling af kræft, indeholdende lactatmetalsalt | |
| JP2014508784A5 (https=) | ||
| JP2017531686A5 (https=) | ||
| EP3566705A4 (en) | COMPOSITION FOR THE PREVENTION OR TREATMENT OF METASTATIC OVARIAN CANCER, ENDOMETRIC CANCER OR BREAST CANCER | |
| JP2019521155A5 (https=) |